Maryland HB1435 mandates health insurance coverage for hormone-related care, including hormone therapy for perimenopausal and menopausal symptoms.
Maryland HB1435 requires insurers and health maintenance organizations to cover hormone-related care, including hormone replacement therapy, hormone suppression or modulation therapy, hormone-modulating medications, and related clinical visits. The bill prohibits insurers from denying coverage based on diagnosis, patient age, or prior use of hormone-related care. It also mandates that insurers provide timely access to in-network providers and prohibits more burdensome requirements for hormone-related care compared to other treatments.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.